Tag: Enter

Posted on

AstraZeneca asthma drug hits goal, to enter competitive market – Reuters


Reuters

AstraZeneca asthma drug hits goal, to enter competitive market
Reuters
L) drive to rebuild its portfolio of new medicines received a boost with positive results for an experimental biotech drug for severe asthma that the company previously flagged as a potential $2 billion-a-year seller. Benralizumab, which is likely to …
AstraZeneca: Asthma drug trial results positiveMarketWatch
Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe AsthmaNasdaq
TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial ResultsLondon South East (registration) (blog)

all 6 news articles »

View full post on asthma – Google News

Posted on

BioLineRx’s EDP-14, for Treatment of Severe and Persistent Asthma, to Enter … – PharmaLive (press release) (subscription)

BioLineRx's EDP-14, for Treatment of Severe and Persistent Asthma, to Enter …
PharmaLive (press release) (subscription)
BL-9010, a novel bi-specific antibody treatment for severe and persistent asthma, targets and links together two immunological modulators – IgE and CD300a. Allergen-bound IgE activates cells involved in allergic responses, such as mast cells, while …

and more »

View full post on asthma – Google News

Posted on

BioLineRx’s EDP-14, for Treatment of Severe and Persistent Asthma, to Enter … – MarketWatch (press release)

BioLineRx's EDP-14, for Treatment of Severe and Persistent Asthma, to Enter …
MarketWatch (press release)
BL-9010, a novel bi-specific antibody treatment for severe and persistent asthma, targets and links together two immunological modulators – IgE and CD300a. Allergen-bound IgE activates cells involved in allergic responses, such as mast cells, while …
BIOLINERX LTD. : BioLineRx's EDP-14, for Treatment of Severe and Persistent …4-traders (press release)

all 2 news articles »

View full post on asthma – Google News